Related Experiment Video
Updated: Apr 30, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
34.4K
Defining phenotypes in asthma: a step towards personalized medicine
1Experimental Studies, National Heart and Lung Institute, Imperial College London, Dovehouse St, London, SW3 6LY, UK, f.chung@imperial.ac.uk.
Drugs
|May 7, 2014
Summary
Asthma presents with diverse phenotypes, requiring personalized treatment strategies beyond current step-up approaches. Identifying specific asthma subtypes, like eosinophilic or non-eosinophilic, is crucial for effective therapy and improved patient outcomes.
Area of Science:
- Pulmonology
- Immunology
- Genetics
Background:
- Asthma is a complex respiratory disease with varied clinical presentations and severity.
- Current treatment guidelines emphasize a step-up approach based on symptom severity.
- Severe asthma is increasingly recognized as a heterogeneous condition necessitating advanced diagnostic methods.
Purpose of the Study:
- To explore distinct asthma phenotypes using unbiased cluster analysis.
- To identify biomarkers for predicting therapeutic responses.
- To highlight the need for personalized medicine in severe asthma management.
Main Methods:
- Cluster analysis of patient cohorts across the full spectrum of asthma severity.
- Analysis of sputum eosinophilia as a predictive biomarker.
- Review of current treatment strategies and future directions in asthma phenotyping.
Main Results:
- Identification of several distinct asthma phenotypes, including severe forms characterized by high-dose corticosteroid use and airflow obstruction.
- Eosinophilic phenotypes linked to specific clinical features and predictive of response to anti-interleukin-5 (IL-5) therapies.
- Low T-helper (Th) 2-expression associated with poor response to inhaled corticosteroids.
Conclusions:
- Asthma phenotyping is essential for developing targeted treatment strategies, especially in severe and heterogeneous cases.
- Biomarkers like sputum eosinophilia are vital for predicting treatment efficacy.
- Advanced technologies like transcriptomics and proteomics, coupled with systems biology, will drive personalized asthma medicine.
Related Concept Videos
01:29Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
01:26Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
01:13Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49